Aprocitentan Side Effects
Medically reviewed by Drugs.com. Last updated on Jan 10, 2025.
Applies to aprocitentan: oral tablets film-coated.
Important warnings
This medicine can cause some serious health issues
REMS:
FDA approved a REMS for aprocitentan to ensure that the benefits outweigh the risks.
The REMS may apply to one or more preparations of aprocitentan and consists of the following: elements to assure safe use and implementation system.
See the FDA REMS page at [Web]
Side effects include:
Adverse effects reported in ≥2% of patients receiving aprocitentan include edema/fluid retention and anemia.
See also:
For healthcare professionals
Applies to aprocitentan: oral tablet.
General adverse events
The most frequently reported side effects included anemia, edema, and fluid retention.[Ref]
Dermatologic
- Frequency not reported: Allergic dermatitis, erythema, rash
Hematologic
- Common (1% to 10%): Anemia/decreased hemoglobin
- Frequency not reported: Decreased hematocrit
Hepatic
- Frequency not reported: Hepatotoxicity, increased aminotransferases, increased ALT, increased AST
Hypersensitivity
- Uncommon (0.1% to 1%): Hypersensitivity
- Frequency not reported: Allergic edema
Hypersensitivity included rash, erythema, and allergic edema.
Metabolic
- Common (1% to 10%): Edema/fluid retention
Renal
- Frequency not reported: Decrease in estimated GFR
References
1. (2024) "Product Information. Tryvio (aprocitentan)." Idorsia Pharmaceuticals US Inc.
More about aprocitentan
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- Drug class: miscellaneous cardiovascular agents
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Aprocitentan side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.
